Eli Lilly (LLY) Total Current Liabilities (2016 - 2025)
Eli Lilly's Total Current Liabilities history spans 17 years, with the latest figure at $35.2 billion for Q4 2025.
- For Q4 2025, Total Current Liabilities rose 24.15% year-over-year to $35.2 billion; the TTM value through Dec 2025 reached $35.2 billion, up 24.15%, while the annual FY2025 figure was $35.2 billion, 24.15% up from the prior year.
- Total Current Liabilities reached $35.2 billion in Q4 2025 per LLY's latest filing, down from $40.1 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $40.1 billion in Q3 2025 to a low of $11.7 billion in Q1 2021.
- Average Total Current Liabilities over 5 years is $22.2 billion, with a median of $18.8 billion recorded in 2023.
- Peak YoY movement for Total Current Liabilities: dropped 7.11% in 2021, then surged 62.68% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $15.1 billion in 2021, then increased by 13.85% to $17.1 billion in 2022, then soared by 59.25% to $27.3 billion in 2023, then increased by 3.97% to $28.4 billion in 2024, then increased by 24.15% to $35.2 billion in 2025.
- Per Business Quant, the three most recent readings for LLY's Total Current Liabilities are $35.2 billion (Q4 2025), $40.1 billion (Q3 2025), and $39.0 billion (Q2 2025).